세계의 규제 승인 앱 시장 - 시장 규모(부문별), 점유율, 규제, 상환, 예측(-2036년)

Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

US $ 7,500 ￦ 10,809,000

Excel (Single User License)

Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 15,000 ￦ 21,619,000

Excel (Site License)

Excel 보고서를 동일 기업의 한 부서에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 22,500 ￦ 32,429,000

Excel (Global License)

Excel 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 규제 승인 앱 시장에 대해 조사 분석했으며, 각 지역별 시장 규모, 주요 동향, 혁신적인 제품 및 기술, 경쟁 구도 등의 정보를 전해드립니다.

시장 모델의 주요 내용은 다음과 같습니다.

이미 출시된 규제 승인 앱과 진화하는 경쟁 구도

• 주요 산업 동향 인사이트
• 규제 승인 앱 시장의 각 부문별 연간 매출 및 시장 전망(2015-2036년)
• 각 부문의 총 개입 수, 유닛 수, 평균 판매 가격, 시장 금액에 대한 상세 데이터

세계, 지역, 국가 단위의 각 시장 인사이트

• 세계 동향을 지역별로 분류한 정성적인 각 시장 정보 및 각국 시장 인사이트
• 규제 승인 앱 시장 SWOT 분석
• 규제 당국 승인 앱 시장의 경쟁 역학에 대한 인사이트와 동향

의료제도의 개요를 포함한 진정한 전체 그림을 파악하여 시장에 대한 이해를 돕습니다. 또한, 시장 진입 부문에서는 상환 정책 및 규제 환경에 대한 정보를 제공하여 시장 역학에 대한 심층적인 이해를 돕습니다.

• 각국의 의료제도 개요
• 각국의 상환 정책
• 각국의 의료기술 관련 규제 현황

대상 기업

• Akili Interactive Labs, Inc.
• Abbott Laboratories
• Johnson & Johnson Medical GmbH
• Medtronic, Inc
• Otsuka Pharmaceutical Co., Ltd.
• Stryker Corp
• Dexcom Inc
• Livongo Health Inc
• 기타

ksm

영문 목차

영문목차

Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Digital Health therapeutic area.

Regulatory Approved Apps refers to mobile applications, usually installed on a Smart Phone or Tablet computer, that have been approved by the relevant national regulator to act as a medical device.

Regulatory Approved Apps are specifically developed for the iOS or android mobile phone platforms. Many require a prescription to access and qualify as digital therapeutics. Regulated apps are a relatively new market being categorized as medical devices. There is a large difference in the quality of apps available as wellness aids and those that have met the regulatory burden to meet regulatory approval. There are many different regulatory bodies that may or may not yet recognize mobile apps as having medical device capabilities. While almost any condition can benefit in some way from a regulated app.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with value, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Regulatory Approved Apps and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Regulatory Approved Apps market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Regulatory Approved Apps market.
• Competitive dynamics insights and trends provided for Regulatory Approved Apps market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered : Akili Interactive Labs, Inc., Abbott Laboratories, Johnson & Johnson Medical GmbH, Medtronic, Inc, Otsuka Pharmaceutical Co., Ltd., Stryker Corp, Dexcom Inc, Livongo Health Inc, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Regulatory Approved Apps marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving the Regulatory Approved Apps market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Regulatory Approved Apps market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Regulatory Approved Apps 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

관련자료